Your browser doesn't support javascript.
loading
MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming.
Anand, Shashi; Khan, Mohammad Aslam; Zubair, Haseeb; Sudan, Sarabjeet Kour; Vikramdeo, Kunwar Somesh; Deshmukh, Sachin Kumar; Azim, Shafquat; Srivastava, Sanjeev Kumar; Singh, Seema; Singh, Ajay Pratap.
Afiliação
  • Anand S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Khan MA; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Zubair H; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Sudan SK; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Vikramdeo KS; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Deshmukh SK; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Azim S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Srivastava SK; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Singh S; Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Singh AP; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
EMBO Rep ; 24(3): e55643, 2023 03 06.
Article em En | MEDLINE | ID: mdl-36592158

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article